Blood and Serum DNA Isolation Kit |
K5017100 |
Biochain |
1 kit |
EUR 355 |
Blood Serum Laboratories manufactures the b-12 blood serum reagents distributed by Genprice. The B-12 Blood Serum reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Blood Serum. Other B-12 products are available in stock. Specificity: B-12 Category: Blood Group: Serum
Mouse Serum |
Abbexa |
5 L |
EUR 10599.6 |
|
Mouse Serum |
Abbexa |
1 ml |
EUR 2064 |
|
Porcine Serum |
Abbexa |
1 L |
EUR 710.4 |
|
Rabbit Serum |
Abbexa |
100 ml |
EUR 326.4 |
|
Rabbit Serum |
Abbexa |
500 ml |
EUR 577.2 |
|
Rat Serum |
Abbexa |
10 ml |
EUR 326.4 |
|
Sheep Serum |
Abbexa |
100 ml |
EUR 410.4 |
|
Serum information
ABO Antibody (Blood Group Antigen B) |
V2551-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: The antibody HEB-29 reacts with human blood group B. The specificity of the antibody HEB-29 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. mAb HEB-29 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. It is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens. |
ABO Antibody (Blood Group Antigen B) |
V2551SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: The antibody HEB-29 reacts with human blood group B. The specificity of the antibody HEB-29 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. mAb HEB-29 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. It is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens. |
ABO Antibody (Blood Group Antigen B) |
V2552-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens. |
ABO Antibody (Blood Group Antigen B) |
V2552-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens. |
ABO Antibody (Blood Group Antigen B) |
V2552IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens. |
ABO Antibody (Blood Group Antigen B) |
V2552SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens. |
anti-B human blood group antigen IgM |
140-A-01mg |
Virogen |
0,1 mg |
EUR 321 |
|
Description: anti-B human blood group antigen IgM |
anti-B human blood group antigen IgM |
140-A-1000ug |
Virogen |
1000 ug |
EUR 1539 |
|
Description: anti-B human blood group antigen IgM |
anti-B human blood group antigen IgM |
140-A-100ugvial |
Virogen |
100 ug/vial |
EUR 150 |
|
Description: anti-B human blood group antigen IgM |
Blood group antigen B(HEB-29) Antibody |
BNC941065-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Blood group antigen B(HEB-29), CF594 conjugate, Concentration: 0.1mg/mL |
Blood group antigen B(HEB-29) Antibody |
BNC941065-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Blood group antigen B(HEB-29), CF594 conjugate, Concentration: 0.1mg/mL |
Blood group antigen B(HEB-29) Antibody |
BNC801065-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Blood group antigen B(HEB-29), CF680 conjugate, Concentration: 0.1mg/mL |
Blood group antigen B(HEB-29) Antibody |
BNC801065-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Blood group antigen B(HEB-29), CF680 conjugate, Concentration: 0.1mg/mL |
Blood group antigen B(HEB-29) Antibody |
BNC811065-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Blood group antigen B(HEB-29), CF680R conjugate, Concentration: 0.1mg/mL |